Johnson & Johnson JNJ

271.22 0.54 0.20% as of 25 Sep
Market cap
$652.8B
P/E
31.4×
Indexes indicate stock being part of an index,
Growth Flags show if company had growth for consecutive years,
Insider Buys alert about insiders buying in the last 12 month

An Income Statement, also known as a Profit and Loss Statement, summarizes a company's revenues, expenses, and profits over a specific period. It highlights how revenue is transformed into net income, showcasing operational efficiency. Key components include total revenue, cost of goods sold (COGS), gross profit, operating expenses, and net profit. Businesses use the Income Statement to assess financial performance, make strategic decisions, and ensure profitability. Investors and stakeholders analyze it to gauge the company’s financial health and future growth potential.

Older periods Sep '25 Dec '25 Mar '26 Jun '26
Revenue

+8 more TTM periods

92,149.00 94,193.00 96,362.00 97,929.00
Cost of Revenue
29,416.00 30,256.00 31,005.00 31,428.00
Gross Profit
62,733.00 63,937.00 65,357.00 66,501.00
R&D Expenses
15,711.00 14,665.00 14,967.00 15,104.00
SG&A Expenses
23,376.00 23,676.00 24,598.00 25,141.00
Operating Income
31,502.00 32,581.00 24,940.00 25,196.00
Interest Expense (Operating)
894.00 971.00 1,039.00 1,012.00
EBT
31,502.00 32,581.00 24,940.00 25,196.00
Income Tax Provision
6,383.00 5,777.00 3,900.00 4,159.00
Income after Tax
25,119.00 26,804.00 21,040.00 21,037.00
Net Income Common
25,119.00 26,804.00 21,040.00 21,037.00
EPS (Basic)
10.36 11.05 8.65 8.63
Gross Margin
68.08% 67.88% 67.82% 67.91%
EBIT Margin
36.35% 36.74% 27.95% 27.69%
EBT margin
34.19% 34.59% 25.88% 25.73%
Net Profit Margin
27.26% 28.46% 21.83% 21.48%
Free Cash Flow Margin
21.77% 21.68% 18.94% 23.20%
EBITDA
40,884.00 42,111.00 34,667.00 34,871.00
EBIT
33,496.00 34,608.00 26,932.00 27,120.00
EPS (Diluted, from Cont. Ops)
10.35 11.03 8.63 8.61
EPS (Basic, Consolidated)
10.43 11.13 8.74 8.74
EPS (Basic, from Continuous Ops)
10.43 11.13 8.73 8.73
Income from Continuous Operations
25,119.00 26,804.00 21,040.00 21,037.00
Consolidated Net Income/Loss
25,119.00 26,804.00 21,040.00 21,037.00
EBITDA Margin
44.37% 44.71% 35.98% 35.61%
Operating Cash Flow Margin
26.27% 26.04% 23.73% 28.19%

Fold the line items

In millions of $ except per-share values · columns are period end dates